178 related articles for article (PubMed ID: 34587791)
1. CCL2 (C-C Motif Chemokine Ligand 2) Biomarker Responses in Central Versus Peripheral Compartments After Focal Cerebral Ischemia.
Shi J; Li W; Zhang F; Park JH; An H; Guo S; Duan Y; Wu D; Hayakawa K; Lo EH; Ji X
Stroke; 2021 Nov; 52(11):3670-3679. PubMed ID: 34587791
[TBL] [Abstract][Full Text] [Related]
2. The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials.
Geng H; Chen L; Tang J; Chen Y; Wang L
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408846
[TBL] [Abstract][Full Text] [Related]
3. Upregulated C-C Motif Chemokine Ligand 2 Promotes Ischemic Stroke via Chemokine Signaling Pathway.
Li L; Lou W; Li H; Zhu Y; Huang X
Ann Vasc Surg; 2020 Oct; 68():476-486. PubMed ID: 32422289
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Chemokine (C-C Motif) Ligand 2 Is an Early-Response Biomarker for Blast-Overpressure-Wave-Induced Neurotrauma in Rats.
Wang Y; Wei Y; Oguntayo S; Wilder D; Tong L; Su Y; Gist I; Arun P; Long JB
J Neurotrauma; 2017 Feb; 34(4):952-962. PubMed ID: 27487732
[TBL] [Abstract][Full Text] [Related]
5. CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke.
Stowe AM; Wacker BK; Cravens PD; Perfater JL; Li MK; Hu R; Freie AB; Stüve O; Gidday JM
J Neuroinflammation; 2012 Feb; 9():33. PubMed ID: 22340958
[TBL] [Abstract][Full Text] [Related]
6. Early retinal inflammatory biomarkers in the middle cerebral artery occlusion model of ischemic stroke.
Ritzel RM; Pan SJ; Verma R; Wizeman J; Crapser J; Patel AR; Lieberman R; Mohan R; McCullough LD
Mol Vis; 2016; 22():575-88. PubMed ID: 27293375
[TBL] [Abstract][Full Text] [Related]
7. Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain.
Selenica ML; Alvarez JA; Nash KR; Lee DC; Cao C; Lin X; Reid P; Mouton PR; Morgan D; Gordon MN
J Neuroinflammation; 2013 Jul; 10():86. PubMed ID: 23866683
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of C-C Chemokine Receptor 5 (CCR5) is Protective Against Cerebral Ischemia and Reperfusion Injury.
Victoria ECG; de Brito Toscano EC; de Sousa Cardoso AC; da Silva DG; de Miranda AS; da Silva Barcelos L; Sugimoto MA; Sousa LP; de Assis Lima IV; de Oliveira ACP; Brant F; Machado FS; Teixeira MM; Teixeira AL; Rachid MA
Curr Neurovasc Res; 2017; 14(2):125-131. PubMed ID: 28294064
[TBL] [Abstract][Full Text] [Related]
9. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
Thériault P; Le Béhot A; ElAli A; Rivest S
Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
[TBL] [Abstract][Full Text] [Related]
10. Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
Queck A; Bode H; Uschner FE; Brol MJ; Graf C; Schulz M; Jansen C; Praktiknjo M; Schierwagen R; Klein S; Trautwein C; Wasmuth HE; Berres ML; Trebicka J; Lehmann J
Front Immunol; 2020; 11():354. PubMed ID: 32218781
[No Abstract] [Full Text] [Related]
11. The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain.
Andres RH; Choi R; Pendharkar AV; Gaeta X; Wang N; Nathan JK; Chua JY; Lee SW; Palmer TD; Steinberg GK; Guzman R
Stroke; 2011 Oct; 42(10):2923-31. PubMed ID: 21836091
[TBL] [Abstract][Full Text] [Related]
12. Chemokine C-C motif ligand 2 suppressed the growth of human brain astrocytes under Ischemic/hypoxic conditions via regulating ERK1/2 pathway.
Yu M; Zheng N; Jiang D; Wang L; Zhan Q; Zhao J
Brain Inj; 2020 Jul; 34(9):1277-1282. PubMed ID: 32749897
[TBL] [Abstract][Full Text] [Related]
13. Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke.
Liu XS; Zhang ZG; Zhang RL; Gregg SR; Wang L; Yier T; Chopp M
J Neurosci Res; 2007 Aug; 85(10):2120-5. PubMed ID: 17510981
[TBL] [Abstract][Full Text] [Related]
14. A Mouse Brain-based Multi-omics Integrative Approach Reveals Potential Blood Biomarkers for Ischemic Stroke.
Simats A; Ramiro L; García-Berrocoso T; Briansó F; Gonzalo R; Martín L; Sabé A; Gill N; Penalba A; Colomé N; Sánchez A; Canals F; Bustamante A; Rosell A; Montaner J
Mol Cell Proteomics; 2020 Dec; 19(12):1921-1936. PubMed ID: 32868372
[TBL] [Abstract][Full Text] [Related]
15. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia.
Clark WM; Rinker LG; Lessov NS; Hazel K; Hill JK; Stenzel-Poore M; Eckenstein F
Stroke; 2000 Jul; 31(7):1715-20. PubMed ID: 10884478
[TBL] [Abstract][Full Text] [Related]
16. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice.
Huang D; Wujek J; Kidd G; He TT; Cardona A; Sasse ME; Stein EJ; Kish J; Tani M; Charo IF; Proudfoot AE; Rollins BJ; Handel T; Ransohoff RM
FASEB J; 2005 May; 19(7):761-72. PubMed ID: 15857890
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway.
Wacker BK; Perfater JL; Gidday JM
J Neurochem; 2012 Dec; 123(6):954-62. PubMed ID: 23043544
[TBL] [Abstract][Full Text] [Related]
18. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
Stroke; 2007 Apr; 38(4):1345-53. PubMed ID: 17332467
[TBL] [Abstract][Full Text] [Related]
19. Aging aggravates ischemic stroke-induced brain damage in mice with chronic peripheral infection.
Dhungana H; Malm T; Denes A; Valonen P; Wojciechowski S; Magga J; Savchenko E; Humphreys N; Grencis R; Rothwell N; Koistinaho J
Aging Cell; 2013 Oct; 12(5):842-50. PubMed ID: 23725345
[TBL] [Abstract][Full Text] [Related]
20. Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.
Kim EH; Tolhurst AT; Szeto HH; Cho SH
CNS Neurosci Ther; 2015 Apr; 21(4):385-91. PubMed ID: 25216018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
